Trending Now
Invesco QQQ Trust (QQQ) looks for a solid bounce ahead of...
After being in the $280-$292 range in the QQQ’s for over a month, lower than expected inflation sent the market way outside...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Activist Investing LLC Buys Common Stock From Titan Pharmaceuticals, Inc. (NASDAQ:...
Activist Investing LLC has announced the acquisition of Titan Pharmaceuticals, Inc's. (NASDAQ: TTNP) common stock. According to Activist Investing’s CEO, David E. Lazar. The...
MAKE IT MODERN
LATEST REVIEWS
The Ascending Trajectory of Purple Biotech Ltd (PPBT): Pioneering Pancreatic Cancer...
Purple Biotech Ltd (NASDAQ/TASE: PPBT), a trailblazer in the oncology sector, is making significant strides with its innovative cancer treatment solutions. Following...
MAKE IT MODERN
PERFORMANCE TRAINING
Ocular Therapeutix™ (NASDAQ:OCUL) Report Net Revenue Of $5.9 Million In Q3 2020 Driven By...
Ocular Therapeutix™ (NASDAQ:OCUL) has announced its Q3 2020 financial results in which DEXTENZA® net product revenue was up 280% QoQ and also provided its...
AutoWeb Inc. (NASDAQ: AUTO) Acquires CarZeus Assets to Its Grow Marketing Capabilities
AutoWeb Inc. (NASDAQ: AUTO) has purchased san Antonio, Texas-based CarZeus’ assets. CarZeus is a used car acquisition platform that buys cars from customers and...
Novavax (NASDAQ:NVAX) Stock Jumps 11% On Plans To Commence Vaccine Trials In The US...
Novavax (NASDAQ:NVAX) stock popped 11% on Monday after the company announced updates from its COVID-19 vaccine trials. The company expects to releases results from...
BridgeBio Pharma Inc (NASDAQ: BBIO) Will Present Data From its Acoramidis Study
BridgeBio Pharma Inc (NASDAQ: BBIO) will feature updated information from its Phase II acoramidis for transthyretin amyloid cardiomyopathy (ATTR) at the Annual Scientific Session...
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) Reports Topline Data For ATTACK Study Evaluating SUL-DUR’s...
Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX) has reported topline data from the ATTACK study. ATTACK trial is a global third phase registration study assessing...
MAKE IT MODERN
